Physician profile
Adam Yanke
NPI 1639335953
$132,352.74
in general payments reported to CMS, 2019-2025
15 companies · $51K in 2025
The $51K reported for 2025 was more than what 95% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,261 · 2020: $3,496 · 2021: $5,288 · 2022: $21K · 2023: $4,136 · 2024: $43K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $66K · Royalty Or License: $17K · Travel and Lodging: $11K · Food and Beverage: $3,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $66,362.50 |
| Royalty Or License | $17,079.18 |
| Travel and Lodging | $11,153.87 |
| Food and Beverage | $3,502.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $117,848.10 | 2020-2025 | Flexible Guide Pin (Stryker Acl Versitomic), Aequalis, Triathlon |
| Joint Restoration Foundation, INC. | $4,174.31 | 2019-2025 | |
| Arthrex, INC. | $4,000.00 | 2021 | |
| Medwest Associates | $2,197.00 | 2019-2020 | |
| Synthes Gmbh | $1,855.90 | 2025 | |
| Olympus America INC. | $1,170.00 | 2019 | |
| Moximed, INC | $425.44 | 2025 | Misha Knee System, Small, Left |
| Aesculap Biologics, LLC | $168.40 | 2019-2023 | Novocart 3d |
| Breg, INC | $124.70 | 2020 | |
| Linvatec Corporation | $96.93 | 2021 | |
| Vericel Corporation | $92.46 | 2020-2022 | |
| Smith+Nephew, INC. | $90.65 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $81.95 | 2022 | |
| Orthofix Medical, INC. | $13.64 | 2023 | Physio-Stim |
| Lightbody Medical Technologies INC | $13.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Yanke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.